This Week in HIV Research: Treatment Does a Body Good

This Week in HIV Research: Treatment Does a Body Good

1 of 5
Next >

There's no requirement that research break new ground for it to be noteworthy. Plenty of important studies are confirmatory, adding strength in numbers to established science -- or providing a timely reminder of prior findings that can always use reinforcement. So it is with some of this week's featured research, which includes:

  • A reinforcement of the myriad health benefits of early, sustained HIV treatment -- including reductions in cardiovascular and cancer risk.
  • Another arrow in the quiver for on-demand pre-exposure prophylaxis (PrEP): Among French men who have sex with men, it's the preferred dosing method.
  • A suggestion from Southern Africa that injectable PrEP, once it's available, may prove more popular than the oral version.
  • A reminder that, to give effective HIV care, providers need to remember the basics -- including frequent syphilis testing for at-risk men who have sex with men.

Whether these findings are news to you or just a refresher, we're eager to share some of the most pertinent details with you here. To beat HIV, you have to follow the science!

Barbara Jungwirth is a freelance writer and translator based in New York. Follow Barbara on Twitter: @reliabletran.

Myles Helfand is the executive editor and general manager of TheBody.com and TheBodyPRO.com. Follow Myles on Twitter: @MylesatTheBody.

Image Credit: vitanovski for iStock via Thinkstock

There's no requirement that research break new ground for it to be noteworthy. Plenty of important studies are confirmatory, adding strength in numbers to established science -- or providing a timely reminder of prior findings that can always use reinforcement. So it is with some of this week's featured research, which includes:

  • A reinforcement of the myriad health benefits of early, sustained HIV treatment -- including reductions in cardiovascular and cancer risk.
  • Another arrow in the quiver for on-demand pre-exposure prophylaxis (PrEP): Among French men who have sex with men, it's the preferred dosing method.
  • A suggestion from Southern Africa that injectable PrEP, once it's available, may prove more popular than the oral version.
  • A reminder that, to give effective HIV care, providers need to remember the basics -- including frequent syphilis testing for at-risk men who have sex with men.

Whether these findings are news to you or just a refresher, we're eager to share some of the most pertinent details with you here. To beat HIV, you have to follow the science!

Barbara Jungwirth is a freelance writer and translator based in New York. Follow Barbara on Twitter: @reliabletran.

Myles Helfand is the executive editor and general manager of TheBody.com and TheBodyPRO.com. Follow Myles on Twitter: @MylesatTheBody.

Image Credit: vitanovski for iStock via Thinkstock